Why These 15 Stocks Are Skyrocketing in 2025

Page 9 of 14

6. Option Care Health (NASDAQ:OPCH)

Number of Hedge Fund Holders In Q3 2024: 31

Option Care Health (NASDAQ:OPCH) provides home and alternative site infusion treatments. It has therapies for heart failure and many other diseases. The company also offers nursing services.

The stock has spiked so far in 2025 due to management reporting strong preliminary financial results for 2024 at about $5 billion in revenue and net income in the range of $208.5 million and $212.6 million. The guidance for 2025 calls for $5.2 billion to $5.4 billion in net revenue.

The company also announced a $500 million stock repurchase program in January and completed the last $90 million of an earlier repurchase plan.

Some analysts have also upgraded the stock, with Jefferies raising its price target to $35 due to the consistent execution along with fewer pricing worries for its Stelara drug.

The analyst consensus price target is $30.8, implying 2.33% upside.

OPCH stock is up 32.62% year-to-date.

Page 9 of 14